Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer - Related Studies

Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer (DOPMET)

This study is currently recruiting participants.

Study NCT00647140. Last updated on March 28, 2008. Information provided by Assistance Publique - Hôpitaux de Paris

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Thyroid Neoplasm
		Thyroid Carcinoma
		Medullary Carcinoma

2	Additional conditions recognized in this trial
		Carcinoma
		Carcinoma, Medullary
		Neoplasms
		Thyroid Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Carcinoma, Neuroendocrine
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Head and Neck Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Ductal, Lobular, and Medullary
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Thyroid Diseases

4	Interventions listed in this trial
		18F-L-DOPA PET

5	Additional drug interventions recognized in this trial
		Dihydroxyphenylalanine
		Levodopa

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antiparkinson Agents
		Central Nervous System Agents
		Dopamine Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Assistance Publique - Hôpitaux de Paris